151 related articles for article (PubMed ID: 31819382)
1. Factors Influencing Participation Of Healthy Volunteers In Clinical Trials: Findings From A Cross-Sectional Study In Delhi, North India.
Ranjan R; Agarwal NB; Kapur P; Marwah A; Parveen R
Patient Prefer Adherence; 2019; 13():2007-2015. PubMed ID: 31819382
[TBL] [Abstract][Full Text] [Related]
2. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
[TBL] [Abstract][Full Text] [Related]
3. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
Fisher JA; McManus L; Kalbaugh JM; Walker RL
Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
[TBL] [Abstract][Full Text] [Related]
5. More than the money: a review of the literature examining healthy volunteer motivations.
Stunkel L; Grady C
Contemp Clin Trials; 2011 May; 32(3):342-52. PubMed ID: 21146635
[TBL] [Abstract][Full Text] [Related]
6. Study of Awareness and Practice of Informed Consent Process Among Clinical Trial Participants and Their Motives Behind Participation.
Ranjan R; Agarwal NB; Kapur P; Marwah A; Parveen R
Asia Pac J Public Health; 2019 Nov; 31(8):710-718. PubMed ID: 31680532
[TBL] [Abstract][Full Text] [Related]
7. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research.
Wang Z; Chen G; Liu X; Liu C; Song Q; Wang J
Eur J Clin Pharmacol; 2021 Apr; 77(4):557-568. PubMed ID: 33188452
[TBL] [Abstract][Full Text] [Related]
8. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
[TBL] [Abstract][Full Text] [Related]
9. Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.
Williams CP; Senft Everson N; Shelburne N; Norton WE
JAMA Netw Open; 2021 Sep; 4(9):e2127792. PubMed ID: 34586365
[TBL] [Abstract][Full Text] [Related]
10. Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials.
Bigorra J; Baños JE
Eur J Clin Pharmacol; 1990; 38(5):443-6. PubMed ID: 2379528
[TBL] [Abstract][Full Text] [Related]
11. Perception of clinical research among patients and healthy volunteers of clinical trials.
Bergmann F; Matzneller P; Weber M; Yeghiazaryan L; Fuereder T; Weber T; Zeitlinger M
Eur J Clin Pharmacol; 2022 Oct; 78(10):1647-1655. PubMed ID: 35896802
[TBL] [Abstract][Full Text] [Related]
12. Incentives for smoking cessation.
Cahill K; Hartmann-Boyce J; Perera R
Cochrane Database Syst Rev; 2015 May; (5):CD004307. PubMed ID: 25983287
[TBL] [Abstract][Full Text] [Related]
13. Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
Nyaoke BA; Mutua GN; Sajabi R; Nyasani D; Mureithi MW; Anzala OA
PLoS One; 2017; 12(9):e0183788. PubMed ID: 28880880
[TBL] [Abstract][Full Text] [Related]
14. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.
Manton KJ; Gauld CS; White KM; Griffin PM; Elliott SL
BMJ Open; 2019 Jan; 9(1):e024224. PubMed ID: 30647042
[TBL] [Abstract][Full Text] [Related]
15. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
[TBL] [Abstract][Full Text] [Related]
16. Why healthy subjects volunteer for phase I studies and how they perceive their participation?
Almeida L; Azevedo B; Nunes T; Vaz-da-Silva M; Soares-da-Silva P
Eur J Clin Pharmacol; 2007 Nov; 63(11):1085-94. PubMed ID: 17891536
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of factors that motivate participants to consent for non-therapeutic trials in India.
Doshi MS; Kulkarni SP; Ghia CJ; Gogtay NJ; Thatte UM
J Med Ethics; 2013 Jun; 39(6):391-6. PubMed ID: 23475804
[TBL] [Abstract][Full Text] [Related]
18. Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.
Hoogerwerf MA; de Vries M; Roestenberg M
BMJ Open; 2020 Jul; 10(7):e033796. PubMed ID: 32713843
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
